Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TELECTRONICS META DDDR 1256 PACER SLATED FOR LAUNCH WITHIN A MONTH; ST. JUDE'S $115 MIL. ACQUISITION DOES NOT INCLUDE ACCUFIX, ENCOR LEAD LIABILITY

This article was originally published in The Gray Sheet

Executive Summary

Telectronics' Meta DDDR 1256 dual chamber, rate responsive bradycardia pacing line is expected to be launched in the U.S. within the next month, St. Jude says. The device incorporates Telectronics' "minute ventilation" physiologic sensor and "automatic mode switching" technologies. St. Jude highlighted the technologies in announcing its $115 mil. acquisition of Telectronics' ailing pacemaker business from parent company Pacific Dunlop Oct. 23.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel